Core Points - The company announced the supplementary election of members for the fourth board's strategic committee and nomination committee [1] - The election was prompted by recent changes in the board members to ensure the normal operation of the committees [1] - The newly appointed members are Li Hongyan for the strategic committee and Wang Jue for the nomination committee, effective immediately [1] Committee Composition - The strategic committee now consists of Wang Yalong (Chairman), Li Hongyan, and Wang Jue [1] - The nomination committee is composed of Yu Luyao (Chairman), Wang Yalong, and Wang Jue [1]

证券代码：688150 证券简称：莱特光电 公告编号：2025-032 陕西莱特光电材料股份有限公司 | 专门委员会 | 成员组成 | | --- | --- | | 战略委员会 | 王亚龙（主任委员）、李红燕、王珏 | | 提名委员会 | 于璐瑶（主任委员）、王亚龙、王珏 | 特此公告。 陕西莱特光电材料股份有限公司董事会 2025 年 5 月 28 日 关于补选公司第四届董事会战略委员会及提名委员会委 员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 陕西莱特光电材料股份有限公司（以下简称"公司"）于 2025 年 5 月 27 日召 开第四届董事会第十三次会议，审议通过了《关于补选公司第四届董事会战略委员 会及提名委员会委员的议案》，现将相关事项公告如下： 鉴于公司第四届董事会成员近期发生变动，为保证公司董事会战略委员会及提 名委员会正常有序开展工作，根据《中华人民共和国公司法》《上海证券交易所科 创板上市公司自律监管指引第 1 号——规范运作》及《公司章程》等相关规定，董 事会推举董事李红燕女士担任董事会战略委 ...

Group 1 - Company Sun Energy plans to repurchase shares worth between 100 million to 200 million yuan for cancellation, with a maximum repurchase price of 6.69 yuan per share [1] - Company Runyang Technology intends to invest up to 300 million yuan in Shanghai Fourier Intelligent Technology Co., with a pre-investment valuation of 8 billion yuan [1] - Company Heng Rui Medicine's subsidiary has received approval for clinical trials of SHR-4712 injection for treating advanced solid tumors [2] Group 2 - Company Lianhuan Pharmaceutical plans to increase capital by 60 million yuan for its wholly-owned subsidiary [2] - Company Hongchang Electronics' subsidiary plans to increase capital by 10 million USD for its other subsidiary [2] - Company Sichuan Meifeng intends to repurchase shares worth between 50 million to 70 million yuan for cancellation, with a maximum repurchase price of 10.07 yuan per share [2] Group 3 - Company Lian Micro plans to liquidate and deregister Jiaxing Kangjing Semiconductor Industry Investment Partnership [4] - Company Jiutian Pharmaceutical has received approval for clinical trials of PDX-04 drug for treating acute gout attacks [5] - Company Pingzhi Information has signed a framework agreement with China Telecom for a GPU computing power project worth approximately 246 million yuan [7] Group 4 - Company Jiu Zhi Tang's subsidiary has initiated Phase II clinical trials for new drug YB211 aimed at treating acute bacterial skin infections [8] - Company Fosun Pharma's subsidiary has received orphan drug designation for HLX22 for gastric cancer treatment in the EU [9] - Company Jianyou Co. plans to repurchase shares worth between 20 million to 40 million yuan for employee stock ownership plans [11] Group 5 - Company Zhi Zheng Co. announced the resignation of its vice president due to personal reasons [13] - Company He Mai Co. signed a cooperation agreement for household photovoltaic systems worth 1 billion yuan [14] - Company Jinan Intelligent's subsidiary won a project bid for electric vehicle charging stations, expected to positively impact performance [16] Group 6 - Company Gaotie Electric plans to distribute a cash dividend of 0.012 yuan per share [18] - Company Guyue Longshan plans to distribute a cash dividend of 0.08 yuan per share [18] - Company Yongmaotai's shareholders plan to reduce their holdings by up to 2.66% of the company's shares [19] Group 7 - Company Tian Cheng Technology's subsidiary received a land idle fee notice for 2.1658 million yuan due to project delays [20] - Company Guangri Co. appointed a new vice president and board secretary to enhance governance [21] - Company Design General Institute won multiple major projects totaling approximately 390 million yuan [22] Group 8 - Company Fuxie Environmental signed a significant contract worth 244 million yuan for a sewage treatment project [23] - Company Lujiazui announced the resignation of its vice chairman due to job transfer [24] - Company Three Squirrels' H-share issuance application has been accepted by the CSRC [24] Group 9 - Company Kanghong Pharmaceutical's subsidiary received approval for clinical trials of KH617 for glioblastoma treatment [25] - Company Xin Zhu Co. announced a suspension of trading to plan an asset acquisition from its controlling shareholder [26] - Company Jianxin Co. announced plans for share reductions by several directors and senior management [28]

Core Viewpoint - The management of Lite-On Optoelectronics has undergone significant changes, with five directors resigning amid ongoing share reductions by major shareholders, which raises concerns about the company's governance and future direction [1][2][3] Management Changes - Five directors, including Xue Zhen and Dong Zhenhua, have collectively resigned, with two being recommended by major shareholders [1][2] - The board is being restructured to reduce the number of directors from 11 to 7, indicating a shift in governance strategy [2] Shareholder Activity - Major shareholders Junlian Chengye and Junlian Huicheng have reduced their combined shareholding from 9.48% at IPO to 3.9% as of March 2025, following the expiration of their lock-up period [1][3] - The reduction in shareholding coincides with the management changes, suggesting potential instability or lack of confidence in the company's future [1][3] Fundraising and Project Delays - The company plans to raise up to 300 million yuan through a simplified procedure for specific projects and to supplement working capital, with shareholder approval already obtained [1][4] - The "OLED Terminal Material R&D and Industrialization Project" has faced two delays, now expected to be completed by August 2026, with less than 50% of the investment progress made as of November 2024 [1][4][6] Financial Performance - Lite-On Optoelectronics reported a revenue of 472 million yuan in 2024, a year-on-year increase of 56.9%, and a net profit of 167 million yuan, up 117.17% [4] - In Q1 2025, the net profit reached 60.87 million yuan, reflecting a growth of 39.90% compared to the previous year [4] Production Capacity and Market Response - As of the end of 2024, the company has established an annual production capacity of 12 tons for OLED terminal materials, with plans to continue expanding capacity in line with market demand [5] - Despite the high growth in sales revenue, the company has faced scrutiny regarding its ability to meet production timelines and manage project delays effectively [5][6]

Core Points - The company, Shaanxi Light Optical Materials Co., Ltd., has announced a differentiated cash dividend distribution plan for the fiscal year 2024, with a proposed cash dividend of 0.13 RMB per share (including tax) [1][2] - The total cash dividend to be distributed amounts to approximately 52.16 million RMB, which represents 31.18% of the company's net profit attributable to shareholders for the fiscal year 2024 [2] - The dividend distribution will not include capital reserve transfers or stock dividends, maintaining the total number of circulating shares [1][2] Dividend Distribution Details - The cash dividend will be distributed to all shareholders registered by the close of trading on the equity registration date, excluding shares held in the company's repurchase account [1][3] - The reference price for the ex-dividend trading will be calculated based on the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio), with the circulating shares ratio being 0 due to no changes in circulating shares [2] - The company will handle the distribution of cash dividends for specific shareholders, including certain individuals and investment firms [4] Taxation Information - For individual shareholders holding unrestricted circulating shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.13 RMB per share [5] - For those holding shares for less than one year, a tax rate of 20% applies, with the actual tax burden being 10% for holdings between one month and one year [5][6] - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied to their dividends, resulting in a net cash dividend of 0.117 RMB per share [6][7] Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the company's board office at the provided phone number [7]

中信证券股份有限公司 关于陕西莱特光电材料股份有限公司 差异化权益分派特殊除权除息事项的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为陕西莱 特光电材料股份有限公司（以下简称"莱特光电"或"公司"）首次公开发行股 票并在科创板上市的保荐人，根据《中华人民共和国公司法》《中华人民共和国 证券法》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等法律 法规及规范性文件，对公司 2024 年年度利润分配所涉及的差异化分红事项（以 下简称"本次差异化分红"）进行了核查，具体情况如下： 一、本次差异化权益分派方案 根据公司分别于 2025 年 4 月 8 日、2025 年 5 月 6 日召开的第四届董事会第 十次会议及 2024 年年度股东会审议通过的《关于公司 2024 年年度利润分配方案 的议案》，公司 2024 年年度拟以实施权益分派股权登记日登记的总股本扣减公司 回购专用证券账户中的股份为基数，向全体股东每 10 股派发现金红利 1.30 元（含 税），不进行资本公积金转增股本、不送红股。如在公司 2024 年年度利润分配方 案披露之日起至实施权益分派股权登记日期间公司总股本 ...

证券代码：688150 证券简称：莱特光电 公告编号：2025-031 陕西莱特光电材料股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 每股现金红利0.13元（含税） 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/5/29 | 2025/5/30 | 2025/5/30 | 一、 通过分配方案的股东会届次和日期 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定， 是否涉及差异化分红送转：是 每股分配比例 上市公司回购专用证券账户中的股份，不享有股东会表决权、利润分配、公积金转增股 本等权利。 3. 差异化分红送转方案： （1） 差异化分红方案 根据公司 2024 年年度股东会审议通过的《关于公司 2024 年年度利润分配方案的议 案》，公司 2024 年年度拟以实施权益分派股权登记日登记的总股本扣减公司回购专用证 券账户中的股份为基数，向全体股东每 10 股派发现 ...

Board Resignation - The board of directors of Shaanxi Light Optical Materials Co., Ltd. received resignation letters from five directors, including Xue Zhen, Dong Zhenhua, Fan Qihui, Ma Ruopeng, and independent director Li Xianggao, to optimize the corporate governance structure [1][2] - The company will reduce the number of board members by four, including at least two directors who also serve as senior management, in compliance with the Company Law and the company's articles of association [2][3] Impact of Resignation - The resignations will not lead to a decrease in the board's membership below the legal minimum, nor will it affect the proportion of independent directors or the presence of accounting professionals on the board [4] - The resignations are effective immediately upon delivery to the board, except for Li Xianggao, whose resignation will take effect after the election of a new member to the nomination committee [3][4] Election of Employee Director - The company has elected Zhao Xiaohui as the employee director, whose term will last until the end of the current board's term [5] - Zhao Xiaohui has a background in chemical engineering and has held various positions in procurement and management within the company and other organizations [5][6]

证券代码：688150 证券简称：莱特光电 公告编号：2025-030 陕西莱特光电材料股份有限公司 关于公司董事离任及选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事离任情况 （一）提前离任的基本情况 陕西莱特光电材料股份有限公司（以下简称"公司"）董事会近日收到公司董事 薛震先生、董事董振华先生、董事范奇晖先生、董事马若鹏先生、独立董事李祥高先 生递交的书面辞职报告。 为进一步优化公司法人治理结构，公司于2025年4月22日召开第四届董事会第十二 次会议、于2025年5月6日召开2024年年度股东会，分别审议通过《关于公司调整董事 会人数、取消监事会暨修订<公司章程>及其附件的议案》，同意公司将董事会人数由 11名调整为7名，其中非独立董事3名，独立董事3名，职工董事1名，并同步根据相关 法律法规修订《陕西莱特光电材料股份有限公司章程》（以下简称"《公司章程》"）。 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上海证券交易所 科创板上市公司自律监管指引第1号——规范运作》（以下简 ...

Investment Rating - The report maintains an "Outperform" rating for the chemical industry, indicating a positive outlook based on expected economic recovery and demand improvement [1]. Core Insights - The basic chemical industry is expected to see a recovery in profitability, with 2024 revenues projected to reach CNY 2,219.98 billion, a year-on-year increase of 2.66%, while net profit is expected to decline by 8.18% to CNY 108.87 billion [6][26]. - The oil and petrochemical sector is anticipated to maintain stable revenues and profits, with 2024 revenues estimated at CNY 7,941.40 billion, a decrease of 2.81%, and net profit expected to grow by 0.58% to CNY 372.14 billion [1][26]. - The report highlights that 23 out of 33 sub-industries in the basic chemical sector experienced revenue growth in 2024, with significant increases in chlor-alkali and textile chemicals [6][15]. Summary by Sections Industry Overview - The basic chemical industry is experiencing a decline in profitability, with gross and net profit margins at 16.27% and 5.13%, respectively, both down from 2023 [26]. - The report notes that the industry has been in a continuous decline in profitability from 2022 to 2024, but signs of stabilization are emerging [26]. Sub-Industry Performance - In 2024, chlor-alkali and textile chemicals showed the highest profit growth rates at 262.84% and 125.27%, respectively [15][26]. - Conversely, non-metallic materials and other plastic products faced significant profit declines of 79.24% and 67.49% [15][26]. Quarterly Analysis - For Q4 2024, the basic chemical industry reported revenues of CNY 565.72 billion, a year-on-year increase of 5.15%, but a quarter-on-quarter decline of 0.90% [6][7]. - Net profit for Q4 2024 was CNY 14.16 billion, down 10.73% year-on-year and 51.03% quarter-on-quarter [6][7]. Investment Recommendations - The report suggests focusing on companies in rapidly developing downstream sectors, particularly in new materials, energy security, and policy-driven demand recovery [1][26]. - Recommended companies include China National Petroleum, China National Offshore Oil, and various technology firms in the semiconductor and new energy materials sectors [1][26].